Otsuka Holdings CO Ltd (OTSKF)

Otsuka Holdings Co Ltd was established on July 8, 2008 as a holding company. The Company is a healthcare company that aims to contribute to the well-being of people in various regions through its products. It operates in two core businesses: the pharmaceutical business, which supports the diagnosis and treatment of disease; and the nutraceutical business, which supports the maintenance and improvement of day-to-day well-being. The Company conducts its business in four reportable segments: pharmaceuticals, nutraceuticals, consumer products and other businesses. Its pharmaceuticals segment is composed of research and development, production and sales of prescription drugs and clinical nutrition. Its nutraceuticals segment is composed of production and sales of functional foods, over-the-counter drugs and supplements. Its consumer products segment is composed of mineral water, beverages, and food products. Its other segment encompasses other operations, composed of logistics, warehousing, chemical products, and electronics. The Company is subject to applicable laws and regulations in Japan and other jurisdictions that regulate pharmaceutical products, including approval processes that involve significant uncertainties in terms of the length of time required for approval and whether the products meet the criteria of regulatory authorities with respect to efficacy and safety requirements.